单细胞方法鉴定驱动恶性造血干细胞自我更新的分子网络
该研究以JAK2V617F突变骨髓增殖性肿瘤小鼠为模型,用单细胞基因表达和功能实验发现部分JAK2V617F突变造血干细胞自我更新缺陷,该缺陷在单细胞水平可被缺失TET2所挽救,并鉴定出Bmi1等调控基因可驱动疾病表型并维持干细胞自我更新。
要点
- 单细胞功能实验显示部分JAK2V617F突变造血干细胞存在自我更新缺陷。
- 在单细胞水平,缺失TET2可挽救JAK2V617F突变造血干细胞的自我更新缺陷。
- Bmi1过表达(Pbx1和Meis1程度较轻)可在功能实验中驱动疾病表型并维持持久的干细胞自我更新。
核心结论
- 单细胞方法细化了参与骨髓增殖性肿瘤克隆扩增的分子,并对解析正常与恶性干细胞的分子网络具有广泛意义。
研究设计与样本
- 研究以JAK2V617F突变骨髓增殖性肿瘤小鼠为模型,采用单细胞基因表达谱和功能实验分析造血干细胞。
主要发现
- 单细胞基因表达和功能实验鉴定出一部分JAK2V617F突变造血干细胞存在自我更新缺陷。
- 将JAK2V617F小鼠与缺失TET2的小鼠杂交后,该缺陷在单个造血干细胞水平被挽救。
- JAK2V617F突变造血干细胞的单细胞基因表达谱显示特定调控基因丢失,其中一些在单个TET2/JAK2突变造血干细胞中恢复至正常水平。
- 在JAK2突变造血干细胞中过表达Bmi1以及程度较轻的Pbx1和Meis1,可在功能实验中驱动疾病表型并维持持久的干细胞自我更新。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Recent advances in single-cell technologies have permitted the investigation of heterogeneous cell populations at previously unattainable resolution. Here we apply such approaches to resolve the molecular mechanisms driving disease in mouse hematopoietic stem cells (HSCs), using JAK2V617F mutant myeloproliferative neoplasms (MPNs) as a model. Single-cell gene expression and functional assays identified a subset of JAK2V617F mutant HSCs that display defective self-renewal. This defect is rescued at the single HSC level by crossing JAK2V617F mice with mice lacking TET2, the most commonly comutated gene in patients with MPN. Single-cell gene expression profiling of JAK2V617F-mutant HSCs revealed a loss of specific regulator genes, some of which were restored to normal levels in single TET2/JAK2 mutant HSCs. Of these, Bmi1 and, to a lesser extent, Pbx1 and Meis1 overexpression in JAK2-mutant HSCs could drive a disease phenotype and retain durable stem cell self-renewal in functional assays. Together, these single-cell approaches refine the molecules involved in clonal expansion of MPNs and have broad implications for deconstructing the molecular network of normal and malignant stem cells.
引用
- Shepherd MS, Li J, Wilson NK, et al. Single-cell approaches identify the molecular network driving malignant hematopoietic stem cell self-renewal. Blood. 2018. PMID: 29991556. doi:10.1182/blood-2017-12-821066
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。